top of page

Tieteelliset tutkimukset mRNA:sta

Regulatory and Safety Assessment of COVID-19 mRNA-LNP Genetic Vaccines in Japan, Evidence for Revocation of Approval and Market Withdrawal.pdf

Contamination of vaccines

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada.pdf

Contamination of vaccines

Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination.pdf

A Systematic Review Of Autopsy Findings In Deaths After COVID-19 Vaccination.pdf

Excess mortality

A potential association between COVID-19 vaccination and development of Alzheimer's disease.pdf

Alzheimer

COVID-19 Vaccine-Induced Rhabdomyolysis in a 53-Year-Old Woman.pdf

Acute Pleuropericardial Syndrome Following Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination, A Case Report.pdf

COVID-19 vaccination, all-cause mortality, and hospitalization for cancer, 30-month cohort study in an Italian province.pdf

Cancer

COVID-19 Vaccine-Induced Severe Pneumonitis.pdf

Preumonitis

Long-Term Autoimmune Polyarthritis due to COVID-19 Vaccine.pdf

Autoimmune

Evidence Review of the Adverse Effects of COVID-19 Vaccination and Intramuscular Vaccine Administration.pdf

Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development.pdf

Grinspan Syndrome Associated With Pemphigus Vulgaris Induced by COVID-19 Vaccination.pdf

Fulminant Myocarditis After mRNA COVID-19 Vaccine Evolving to Giant Cell Myocarditis.pdf

Myocarditis & Myopericarditis

New-Onset Palmar Psoriasis Following mRNA COVID-19 Vaccination, A Case Report.pdf

Psoriasis

Review, Calls for Market Removal of COVID-19 Vaccines Intensify as Risks Far Outweigh Theoretical Benefits.pdf

SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway.pdf

HIV

Regulatory and Safety Assessment of COVID-19 mRNA-LNP Genetic Vaccines in Japan, Evidence for Revocation of Approval and Market Withdrawal.pdf

Contamination of vaccines

The EMA covid-19 data leak, and what it tells us about mRNA instability.pdf

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada.pdf

Contamination of vaccines
bottom of page